LRMR PEER ANALYSIS

Larimar Therapeutics Inc — metric-by-metric comparison with peers and the industry median

LRMRLarimar Therapeutics Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value it Duel

Overall Profile & Returns

· Biotechnology

Position Within Industry

0 = weak quartile, 100 = strong quartile

LRMRIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	LRMR	MSB	RTALB	TLX	Ind. Median
P/E	—	—	4.89	—	17.91
P/B	1.76	—	0.61●	6.37	3.51
EV/EBITDA	—	—	74.61●	120.14	14.82
P/S	—	31.61	6.67	3.24●	10.89

Financial Health
Metric	LRMR	MSB	RTALB	TLX	Ind. Median
Current Ratio	4.29●	—	1.21	1.43	5.90
Debt/Equity	2.4%	—	1.2%●	112.3%	10.9%
NetDebt/EBITDA	1.19	—	0.90●	13.13	1.15

Profitability
Metric	LRMR	MSB	RTALB	TLX	Ind. Median
Net Margin	—	-115.3%	136.3%●	-0.9%	-125.7%
ROE	-109.8%	-11.3%	15.1%●	-1.8%	-47.5%
ROA	-87.7%	-8.6%	13.1%●	-0.7%	-35.8%
EBITDA Margin	—	-76.6%	9.0%●	3.0%	-105.8%

Growth + Dividend
Metric	LRMR	MSB	RTALB	TLX	Ind. Median
Rev. Growth	-100.0%	410.4%●	24.0%	56.3%	5.1%
NI Growth	—	—	134.0%	—	12.1%
Div. Yield	—	0.0%●	0.0%●	—	0.2%
Payout	—	0.0%	0.0%	—	0.0%

Valuation
Metric	LRMR	PROK	MGNX	LYEL	OABI	SGMT	Ind. Median
P/E	—	—	—	—	—	—	17.91
P/B	1.76	-0.28●	14.10	1.12	1.18	2.42	3.51
EV/EBITDA	—	—	—	—	—	—	14.82
P/S	—	324.08	1.90●	9,914.77	10.74	—	10.89

Financial Health
Metric	LRMR	PROK	MGNX	LYEL	OABI	SGMT	Ind. Median
Current Ratio	4.29	9.06	1.90	7.23	4.80	20.34●	5.90
Debt/Equity	2.4%	-0.4%●	172.2%	17.9%	7.5%	0.0%	10.9%
NetDebt/EBITDA	1.19	1.47	2.32	0.86●	0.87	2.27	1.15

Profitability
Metric	LRMR	PROK	MGNX	LYEL	OABI	SGMT	Ind. Median
Net Margin	—	-8,418.0%	-44.8%●	-794,858.1%	-187.7%	—	-125.7%
ROE	-109.8%	—	-140.3%	-80.8%	-20.2%●	-36.0%	-47.5%
ROA	-87.7%	-21.4%	-31.8%	-63.1%	-18.1%●	-34.3%	-35.8%
EBITDA Margin	—	-16,919.8%	-32.2%●	-770,932.3%	-117.0%	—	-105.8%

Growth + Dividend
Metric	LRMR	PROK	MGNX	LYEL	OABI	SGMT	Ind. Median
Rev. Growth	-100.0%	190.5%●	3.1%	-52.3%	8.1%	—	5.1%
NI Growth	—	—	—	—	—	—	12.1%
Div. Yield	—	—	—	—	—	—	0.2%
Payout	—	—	—	—	—	—	0.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on LRMR

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.